A case report describes treatment of a 35-year-old man with metastatic adult neuroblastoma lacking an identifiable primary tumor using high-dose 131I-MIBG followed by autologous stem cell transplantation. The paper also includes a systematic review summarizing only four prior adult cases, highlighting how scarce clinical evidence remains for this presentation and treatment pathway.